GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, today opened its new 210,000 square-foot North American headquarters in Marlborough, Massachusetts. At full capacity in 2017, it will employ more than 500 scientists and professionals in the Boston area focused on accelerating precision medicine across a portfolio including:
- Manufacturing technologies for cell and immune therapies that are showing the potential to cure some of the world’s toughest diseases, such as cancer
- Early stage research tools used to develop the next generation of precision medicines
- Technologies and consumables for manufacturing vaccines, insulin and the rapidly growing new class of drugs known as biologics
- Leading-edge contrast agents and nuclear medicine tracers that clinicians use to diagnose disease
The new facility at 100 Results Way will be home to 40,000 square feet of laboratories supporting cell and immune therapy research and development, early stage drugdevelopment, biomanufacturing, as well as scientific and medical affairs support.
The laboratories will house GE’s ninth global Fast Trak facility, which partners with and trains biotech innovators to discover newdrugs, develop manufacturing workflows, and optimize their biomanufacturing processes. In 2017, the site will also include GE’s FlexFactory manufacturing platform, originally designed in Marlborough, MA, and which pioneered end-to-end, flexible, small batch biologic drug manufacturing.
“General Electric’s ongoing investment in Massachusetts is just the latest proof that the Commonwealth is a global leader in life science innovation, from discovery to manufacturing and commercialization,” said Governor Charlie Baker. “With a deep bench of talent and supportive economic environment, we are excited to have GE Healthcare be a part of Central Massachusetts’ growing workforce and look forward to the advances that will benefit the health and wellbeing of our citizens.”
GE Healthcare’s nearby Westborough, MA, facility will continue to produce single-use products and consumables for biopharmaceutical manufacturing and with GE’s corporate headquarters moving to Boston this summer, by the end of 2016, GE will have nearly 5,000 employees across Massachusetts.
“Two years ago, we began to move our east coast North American operations to the Boston area to better coordinate our focus on patients, clinicians and customers’ needs,” said Kieran Murphy, president and CEO of GE Healthcare’s Life Sciences business. “Having our North American headquarters in the heart of Massachusetts’ rich ecosystem of healthcare, pharma, and biotech brings us closer to key customers, outstanding talent and ground-breaking innovation and is already helping fuel further growth for our business.”
Lead image caption: 100 Results Way Forum (Photo: Business Wire)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
